Metabolism of Branched-chain Amino Acids in Monocyte/Macrophage During Sepsis
NCT03842371 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2019-02-15
Summary
The current project was designed to examine the metabolic level of branched-chain amino acids in plasm and monocyte/macrophage, and its role in immune dysfunction during sepsis.
Conditions
- Sepsis Syndrome
Interventions
- OTHER
-
Metabolic level of BCAAs in monocytes and macrophages
Metabolic level of BCAAs in monocytes and macrophages
Sponsors & Collaborators
-
West China Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-02-11
- Primary Completion
- 2021-12-30
- Completion
- 2022-02-28
More Related Trials
-
The Th17/Treg Cells and IL-23/IL-17 Axis and Early Enteral Nutrition in Sepsis
NCT03385850 ·Status: COMPLETED ·Phase: NA
-
The Effect of rTEM in the Prognosis and Severity of Sepsis Induced ARDS
NCT06063707 ·Status: NOT_YET_RECRUITING
-
The Role of Myristic Acid in Serum for Early Diagnosis of Sepsis and Comparison With Selected Biomarkers of Sepsis
NCT03314831 ·Status: COMPLETED
-
Relation Between Mean Arterial Pressure and Renal Resistive Index in the Early Phase of Septic Shock
NCT04281277 ·Status: COMPLETED ·Phase: NA
-
Effect of Renin-Angiotensin System on Platelet in Patient With Sepsis
NCT03952390 ·Status: COMPLETED
-
Effects of Dexmedetomidine on Respiratory Function and Inflammatory Responses in Patient With Sepsis Undergoing Cleaning Focus of Infection
NCT02842437 ·Status: UNKNOWN ·Phase: NA
-
Study of Multiple-dose Kukoamine B Mesilate in Sepsis Patients
NCT03237728 ·Status: COMPLETED ·Phase: PHASE1
-
Validation of Molecular and Protein Biomarkers in Sepsis
NCT04289506 ·Status: UNKNOWN
-
Citrulline and Arginase Activity in Severe Sepsis and Septic Shock
NCT03837730 ·Status: COMPLETED
-
Dose-response Study of Arginine Supplementation in Severe Sepsis
NCT01775020 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Glutamine Supplementation in Critically Ill Patients With Severe Sepsis
NCT03048994 ·Status: COMPLETED ·Phase: NA
-
Procalcitonin Monitoring Sepsis Study
NCT01523717 ·Status: COMPLETED
-
Clinical Research on Shenfu Injection in Septic Patients
NCT06157320 ·Status: RECRUITING ·Phase: NA
-
Effect of Enteral Genistein Supplementation in Sepsis
NCT02796794 ·Status: UNKNOWN ·Phase: PHASE4
-
Methylene Blue and Ozone in Early Sepsis
NCT02910765 ·Status: UNKNOWN ·Phase: PHASE4
-
Expression of TIM-3 on Lymphocytes in Sepsis
NCT02319876 ·Status: UNKNOWN
-
Characterization of the Inflammatory Profile of Patients With Macrophage Activation Syndrome Secondary to Bacterial Sepsis
NCT03721809 ·Status: COMPLETED ·Phase: NA
-
Shenfu Injection Improves Arterial Vascular Reactivity
NCT03749525 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
L-Carnitine Administration in Early Sepsis
NCT01193777 ·Status: TERMINATED ·Phase: PHASE1
-
Correlation of Formyl Peptide Receptor 1 With Sepsis-related Encephalopathy
NCT05451537 ·Status: UNKNOWN
-
Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients
NCT05911711 ·Status: UNKNOWN
-
The Efficacy of Xuebijing Injection on Sepsis
NCT03238742 ·Status: COMPLETED ·Phase: PHASE4
-
Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis
NCT03044223 ·Status: RECRUITING
-
Zinc and Inflammation in Sepsis
NCT01328509 ·Status: COMPLETED
-
Prolonged Intravenous Infusion of β-lactam Antibiotics in Early Septic Patients
NCT05024565 ·Status: UNKNOWN ·Phase: NA